IP Verse

Cafa Therapeutics competitive analysis

Latest publications and patents of Cafa Therapeutics New

Explore the latest publications and patents granted to Cafa Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Cafa Therapeutics
EP3445407	Dec 14, 2022	Compositions And Methods Of Cellular Immunotherapy	Granted And Under Opposition
EP3170842	Sep 4, 2019	Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use Thereof	Revoked

Latest patents of Cafa Therapeutics opposed by its competitors

Explore Cafa Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3445407	Dec 14, 2022	Compositions And Methods Of Cellular Immunotherapy	2
EP3170842	Sep 4, 2019	Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use Thereof	1

Latest PTAB cases involving Cafa Therapeutics

Discover the latest PTAB cases involving Cafa Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Cafa Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
CAFA THERAPEUTICS	-	3	-	-	Non-Active
BIONTECH CELL & GENE THERAPIES	1	-	-	-	Highly Aggressive
MURGITROYD	18	-	-	-	Highly Aggressive
SOTIO BIOTECH	1	-	-	-	Highly Aggressive